Hikma Pharmaceuticals USA Inc.

FDA Regulatory Profile

Hikma Pharmaceuticals USA Inc. has 21 FDA recalls (2 Class I), 64 inspections, 0 510(k) clearances and 4 compliance actions on record.

Latest recall
D-0076-2027 · Class II · Oct 6, 2026
Latest inspection
Jul 13, 2026 · VAI

Part of the Hikma Pharmaceuticals corporate family.

Reviewing Hikma Pharmaceuticals USA Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Hikma Pharmaceuticals USA Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls21 (2 Class I)Nov 2, 2026File dated Oct 27, 2026Current
510(k) clearances0Nov 2, 2026File dated Oct 30, 2026Current
Inspections64Nov 7, 2026Newest record Oct 28, 2026Current
Compliance actions4Nov 2, 2026Newest record Oct 29, 2026Current

Related names

NameRecalls510(k)InspectionsComplianceMost recent recall
Hikma Pharmaceuticals
parent company
0050—
Hikma Cali
Same company group
0010—

Recent Recalls

NumberClassProductDate
D-0076-2027Class IIAbirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma…Oct 6, 2026
D-0831-2026Class IIRamipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules…Aug 24, 2026
D-0526-2026Class IIAlendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr…Apr 7, 2026
D-0551-2025Class IILorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley…Jul 22, 2025
D-0635-2024Class IAcetaminophen Injection, 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose bags, For Intravenous…Jul 8, 2024
D-0392-2024Class IIInfumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured…Mar 12, 2024
D-0574-2023Class IILorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per…May 11, 2023
D-0090-2023Class IIGanciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by…Dec 16, 2022
D-1309-2022Class IILorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by…Jul 11, 2022
D-1310-2022Class IILorazepam Injection, USP, 4mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by…Jul 11, 2022
D-1308-2022Class IIAtivan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only…Jul 11, 2022
D-1307-2022Class IILorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by…Jul 11, 2022
D-0771-2021Class IIIBleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by…Aug 5, 2021
D-0169-2021Class IISodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/ml, 2mL Single Dose Vial, Rx Only, Mfd. by…Dec 7, 2020
D-0101-2021Class IISodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/mL, 2mL Single Dose Vial, Preservative Free, For…Nov 3, 2020
D-1533-2020Class IIBuprenorphine HCl Injection, 0.3 mg/mL, 1 mL vial, For Intramuscular or Intravenous Use Only, Rx…Aug 14, 2020
D-1308-2020Class IIIrinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie…Jun 11, 2020
D-1309-2020Class IIIrinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie…Jun 11, 2020
D-0801-2020Class IIImethylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA…Jan 14, 2020
D-0864-2020Class IKetorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC…Dec 17, 2019

Recent FDA Inspections

DateSiteProductClassificationFEI
Jul 13, 2026Berkeley Heights, NJDrugsVoluntary Action Indicated (VAI)3017452050
May 13, 2026Cherry Hill, NJDrugsNo Action Indicated (NAI)2220525
Apr 30, 2026Columbus, OHDrugsNo Action Indicated (NAI)1510690
Jan 17, 2025Columbus, OHDrugsNo Action Indicated (NAI)1510690
Jul 23, 2024Columbus, OHDevicesNo Action Indicated (NAI)1510690
Jun 12, 2024Cherry Hill, NJDrugsVoluntary Action Indicated (VAI)2220525
Nov 3, 2023Cherry Hill, NJDrugsVoluntary Action Indicated (VAI)2220525
Sep 29, 2023Bedford, OHDrugsVoluntary Action Indicated (VAI)3012279857
Dec 15, 2022Bedford, OHDrugsVoluntary Action Indicated (VAI)3012279857
Sep 15, 2022Columbus, OHDrugsNo Action Indicated (NAI)1510690
Jul 7, 2022Cherry Hill, NJDrugsNo Action Indicated (NAI)2220525
Feb 7, 2022Bedford, OHDrugsVoluntary Action Indicated (VAI)3012279857
Jan 31, 2020Bedford, OHDrugsVoluntary Action Indicated (VAI)3012279857
Nov 22, 2019Columbus, OHDrugsNo Action Indicated (NAI)1510690
Sep 10, 2019Cherry Hill, NJDrugsVoluntary Action Indicated (VAI)2220525
Apr 16, 2019Columbus, OHDrugsNo Action Indicated (NAI)1510690
Feb 1, 2019Eatontown, NJDrugsNo Action Indicated (NAI)2250102
Sep 14, 2018Cherry Hill, NJDrugsNo Action Indicated (NAI)2220525
Apr 18, 2018Columbus, OHDrugsVoluntary Action Indicated (VAI)1510690
Apr 13, 2018Eatontown, NJDrugsNo Action Indicated (NAI)2250102

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.